Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Post by beechguyon Nov 13, 2014 1:35pm
343 Views
Post# 23125382

AGM revenue takeaway - $705.6mm

AGM revenue takeaway - $705.6mmI was very perplexed by the pricing and revenue presented. Berendt said there is between 15 and 24 instillations of MNCA every two years at $3000 per instillation. That is $45,000 per patient USD (minimum). 80k BC patients annually in US. 80% are NMIBC (64,000). of those 70% to 80% will become refractory to BCG within two years (44,800 x 70% is 31,360) at a 50% penetration (15,680 x $45,000 = $705,600,000 - on a high margin drug) There are also 600,000 or 800,000 (can't remember the figure) existing BC patients in the US as well. Bioniche's $200,000,000 projected revenue, I don't get. (14% penetration, when your next treatment is your bladder being removed??) Anyone care to explain??? beech
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse